Latest News

Q1 earnings snapshot and why it matters for shareholders Coloplast (CPSE:COLO B) has just reported first quarter results, with sales of DKK 7,043 million, net income of DKK 1,397 million, and basic earnings per share of DKK 6.2 from continuing operations. See our latest analysis for Coloplast. At a share price of DKK485.0, Coloplast has seen a 30 day share price return of 10.65% decline and a year to date share price return of 9.58% decline, while the 1 year total shareholder return of 36.64%...

Carillon Eagle Small Cap Growth Fund recently highlighted Establishment Labs Holdings in its fourth-quarter 2025 investor letter as a leading contributor, citing robust post-FDA-approval demand, strong brand recognition, and clinical advantages. The fund also pointed to tight expense control and a path toward EBITDA profitability and cash flow positivity, underscoring growing confidence in Establishment Labs’ operational progress. We’ll now explore how this endorsement of Establishment Labs’...

If you are looking at Cadence Design Systems and wondering whether the recent price gives you fair value or not, this article will walk through what the numbers actually say. The stock last closed at US$283.46, after a 5.2% decline over the past week and a 10.7% decline over the past month, while still showing a 47.1% return over 3 years and 113.8% over 5 years. Recent moves in the share price are drawing renewed attention to how much investors are willing to pay for Cadence Design Systems...

NewAmsterdam Pharma has begun late stage RUBENS Phase 3 trials of obicetrapib in patients with Type 2 diabetes and metabolic syndrome. The company also plans to launch a new trial of obicetrapib in early Alzheimer's disease. These programs expand obicetrapib's potential use into major cardiometabolic and neurological conditions. For investors watching NasdaqGM:NAMS, these trial moves come as the stock trades at $35.24 and has returned 75.8% over the past year and 237.2% over the past five...

Latest FY 2025 Results Set the Stage for Knife River Knife River (KNF) just wrapped up FY 2025 with Q4 revenue of US$755.1 million and EPS of US$0.56, alongside net income of US$32 million that gives investors a clear read on recent profitability. The company has seen revenue move from US$657.2 million and EPS of US$0.41 in Q4 2024 to US$755.1 million and EPS of US$0.56 in Q4 2025, which feeds directly into trailing 12 month figures of US$3.1 billion in revenue and EPS of US$2.77. With a 5%...

Equitable Holdings recently declared quarterly cash dividends of US$0.27 per common share and payouts on its Series A and C preferred depositary shares, while also reporting lower fourth-quarter and full-year 2025 earnings compared with the prior year. On the same day, the company lifted its equity repurchase authorization by US$1.00 billion to US$4.30 billion, signaling continued focus on capital returns even after buying back US$854 million of stock in the fourth quarter of 2025 and...

John Paulson recently made a large reduction in his stake in Madrigal Pharmaceuticals, while the position still remains his largest holding. Madrigal Pharmaceuticals has approved significant equity inducement awards for new employees as part of recent hiring activity. These developments come as shares of NasdaqGS:MDGL last closed at $487.32. Madrigal Pharmaceuticals, trading under NasdaqGS:MDGL, is drawing attention as a major shareholder reshuffles exposure, while the stock trades at...

Why TAL Education Group Is On Investors’ Radar Today TAL Education Group (NYSE:TAL) has drawn fresh attention after recent share price moves, with the stock down 3.2% over the past day and showing weaker returns across the week, month, past 3 months, and year. See our latest analysis for TAL Education Group. The recent 1 day share price decline of 3.2% to US$10.89 extends a weaker trend, with a 7 day share price return of 11.25% and a 1 year total shareholder return decline of 24.9%,...

Planet Fitness (NYSE:PLNT) has signed a new franchise agreement with Impulso Gym to expand its footprint in Mexico. The company is growing its presence in markets where fitness club penetration is relatively low. Planet Fitness has also appointed Stephen Beard, an experienced executive in education and organizational transformation, to its board of directors. For investors, this move into Mexico highlights how Planet Fitness is focusing on international opportunities where gym membership...

Hacksaw (OM:HACK) has wrapped up FY 2025 with Q4 revenue of €55.1 million and basic EPS of €0.15, supported by trailing 12 month revenue of €197.5 million and EPS of €0.50 against year on year earnings growth of 44.8%. The company has seen quarterly revenue move from €44.0 million and EPS of €0.11 in Q4 2024 to €55.1 million and €0.15 in Q4 2025, while trailing 12 month net income reached €133.6 million alongside a net profit margin of 67.7%. For investors, that combination of expanding...

Wondering whether Insmed's current share price lines up with its underlying value, or if expectations have simply run ahead of the story. The stock last closed at US$150.52, with returns of 1.3% over 7 days, a 6.8% decline over 30 days, a 15.0% decline year to date, and 85.0% over the past year, which naturally raises questions about how much optimism is already in the price. Recent news coverage has focused heavily on Insmed's progress and prospects in the pharmaceuticals and biotech space...

Australian Finance Group H1 2026 Earnings Snapshot Australian Finance Group (ASX:AFG) has put fresh numbers on the table for H1 2026, with trailing 12 month revenue of A$1.3b and basic EPS of A$0.16 framing the latest result. The company has seen revenue move from A$513.6 million in H2 2024 to A$623.4 million in H1 2025 and A$607.5 million in H2 2025, while basic EPS tracked from A$0.054 in H2 2024 to A$0.056 in H1 2025 and A$0.073 in H2 2025. These figures set up this period’s read through...

FY 2025 Headline Results Set the Stage for Sveafastigheter (OM:SVEAF) Sveafastigheter (OM:SVEAF) has wrapped up FY 2025 with fourth quarter revenue of SEK387 million and basic EPS of SEK0.06 loss, rounding out a trailing twelve month EPS of SEK0.42 on revenue of SEK1,536 million and net income of SEK84 million. The company has seen quarterly revenue move from SEK352 million in Q4 2024 to SEK387 million in Q4 2025, while EPS has shifted from SEK1.275 in Q4 2024 to SEK0.06 loss in Q4 2025,...

Viatris has launched Inpefa (sotagliflozin) in the United Arab Emirates, its first commercialization of the therapy outside the U.S. The move marks the beginning of a wider international rollout, with further global expansion planned. The current Viatris (NasdaqGS:VTRS) share price is $15.74. For investors watching Viatris, the Inpefa launch in the UAE puts fresh attention on how the company is building out its branded therapy portfolio beyond the U.S. market. The stock is trading at...

If you are wondering whether Casella Waste Systems at around US$103.88 is priced attractively or asking too much, you are in the right place for a closer look at what that means for you as a shareholder or potential investor. The stock has returned 5.3% year to date, with a 0.3% decline over the last 7 days, a 2.1% decline over 30 days, a 9.7% decline over 1 year, 35.5% total return over 3 years and 75.4% total return over 5 years. Recent news around Casella Waste Systems has largely focused...

BridgeBio Pharma (BBIO) has become a focus for investors after reporting positive topline results from its global Phase 3 PROPEL 3 trial of oral infigratinib in children with achondroplasia. See our latest analysis for BridgeBio Pharma. The positive PROPEL 3 data sits alongside a very strong 1-year total shareholder return of 113.72% and a roughly 7x total shareholder return over 3 years. The 90-day share price return of 15.73% suggests momentum has recently picked up again, despite a softer...

Earnings setback and dividend commitment Mitsubishi Materials (TSE:5711) recently reported nine month results to 31 December 2025 showing lower sales and net income than a year earlier, revised its full year outlook downward, yet kept its dividend plan unchanged. See our latest analysis for Mitsubishi Materials. Despite softer earnings guidance, Mitsubishi Materials' share price has moved sharply higher, with a 17.83% 1 month share price return, 67.68% 3 month share price return, and a...

Roku expanded its free Live TV offering with nine additional channels, broadening its ad supported content lineup. The company is testing Smart TV interface updates that prioritize its own content and advertising inventory on the home screen. These changes aim to deepen user engagement while supporting revenue growth from advertising and Roku branded services. Roku, traded as NasdaqGS:ROKU, is making these product changes as its share price stands at $88.58. The stock has seen a 35.0%...

Some Evolution Mining Limited ( ASX:EVN ) shareholders may be a little concerned to see that the Non-Executive...

The Environmental Group Limited's (ASX:EGL) stock price has dropped 16% in the previous week, but insiders who sold...

If you are looking at Antero Resources and wondering whether the current share price really lines up with its underlying value, you are not alone. The stock last closed at US$33.63, with returns of 4.0% over the past 30 days, a 1.7% decline year to date and a 15.4% decline over the last year. This is set against a 39.1% gain over three years and a 277.0% gain over five years. Recent price moves have kept Antero Resources on the radar for investors who follow US energy names, and the stock...

In early February 2026, EastGroup Properties, Inc. reported higher fourth-quarter and full-year 2025 revenue and net income, alongside diluted earnings per share of US$1.27 for the quarter and US$4.87 for the year, and issued first-quarter and full-year 2026 net income and EPS guidance. A key takeaway is that management’s 2026 outlook, with projected net income attributable to common stockholders between US$263.43 million and US$274.11 million, gives investors a clearer view of expected...

If you are trying to figure out whether Samsara's current share price reflects its real worth, you are not alone. Many investors are asking the same question. The stock recently closed at US$26.16, with a 6.2% decline over the last 7 days, a 25.0% decline over 30 days, a 22.9% decline year to date, and a 57.1% decline over 1 year. However, the 3 year return sits at 61.4%. Recent attention on Samsara has been shaped by ongoing interest in connected operations software and how companies in...

If you are wondering whether Ralph Lauren is still fairly priced after a strong run, you are not alone. This article focuses squarely on what you might be paying for each dollar of the business today. The stock last closed at US$370.50, with returns of 4.0% over the past week, 2.1% over the past month, 2.2% year to date and 30.8% over the past year. The 3 year and 5 year returns of 229.6% and 250.0% show how different holding periods can look. Recent headlines around Ralph Lauren have...